SCM
BRLI

Sarissa Capital Management’s BIO-REFERENCE LABS INC-NEW- BRLI Stock Holding History

Sarissa Capital Management’s Portfolio BRLI Stock Details BRLI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q1 		– Sell
-390,270
Closed -$12.5M – 20
2014
Q4 		$12.5M Sell
390,270
-890,714
-70% -$25.8M 4.44% 6
2014
Q3 		$35.9M Hold
1,280,984
– – 13.88% 3
2014
Q2 		$38.7M Hold
1,280,984
– – 13.16% 4
2014
Q1 		$35.5M Buy
1,280,984
+995,684
+349% +$26.1M 12.21% 3
2013
Q4 		$7.29M Buy
+285,300
New +$8.79M 2.73% 11

Other funds holding BRLI

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Royal Bank of Canada
Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
RP
Riverbridge Partners Minneapolis, Minnesota $3.58B AUM 4.02% 1-Year Est. Return
BTW
Boston Trust Walden Boston, Massachusetts $13.1B AUM 24.63% 1-Year Est. Return
EIP
Epoch Investment Partners New York $16.5B AUM 24.3% 1-Year Est. Return
MRM
Michael R. Murphy $255M AUM 0.87% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Sarissa Capital Management's BRLI Position: Q1 2015 in Review

Sarissa Capital Management sold out of BIO-REFERENCE LABS INC-NEW- (BRLI) in Q1 2015, closing a stake of 390,270 shares — an estimated $12.5M sold.

Sarissa Capital Management first reported a position in BRLI in Q4 2013 and held it in 5 quarters. The position peaked at $38.7M in Q2 2014. 168 funds tracked by Wall St. Rank hold BRLI as of Q1 2015.

  • Sarissa Capital Management reported no remaining BIO-REFERENCE LABS INC-NEW- position as of Q1 2015 after selling out during the quarter.
  • Sarissa Capital Management sold 390,270 BIO-REFERENCE LABS INC-NEW- shares in Q1 2015, an estimated $12.5M.
  • Sarissa Capital Management first reported a position in BIO-REFERENCE LABS INC-NEW- in Q4 2013 and held it in 5 quarters.
  • Sarissa Capital Management's BIO-REFERENCE LABS INC-NEW- position peaked at $38.7M in Q2 2014.
  • 168 funds tracked by Wall St. Rank held BIO-REFERENCE LABS INC-NEW- as of Q1 2015.

Based on Sarissa Capital Management's 13F filing for Q1 2015, filed 15 May 2015.